FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051833837> ?p ?o ?g. }

• W2051833837 endingPage "275" @default.
• W2051833837 startingPage "270" @default.
• W2051833837 abstract "The traditional in vitro approach for assessing potential CYP induction has been to simply compare changes in CYP activities using known CYP-specific probe substrates following exposure to the test compound to that of vehicle and/or positive controls in primary cultured human hepatocytes. The objective of these current studies was to develop and implement a highly efficient 96-well CYP induction assay in which mRNA levels, protein levels, and the conventional enzyme activities of CYP1A2, CYP2B6, and CYP3A4/5 are all measured in the same well after 48 h. Cytotoxicity is also assessed in the same well after 24 and 48 h of incubation. Since enzymatic activity data alone often ‘misses’ CYP induction due to compounding factors, such as CYP mechanism-based inactivation, this ‘all-inclusive’ approach efficiently maximizes the generation of additional useful and comprehensive data. This data can more readily identify potential CYP induction liabilities in the drug discovery process and, therefore, avoid potential drug–drug interactions in the clinic. One 96-well plate with cryopreserved human hepatocytes accommodated up to nine test compounds at three clinically relevant concentrations, positive and negative controls for CYP1A2, CYP2B6, and CYP3A4/5, and a vehicle control (0.1% DMSO) in three different lots of cryopreserved human hepatocytes. Ritonavir, a positive control for CYP3A inactivation/induction, and staurosporine, a positive control for cytotoxicity, were included. The compounds 3-methylcholanthrene (a CYP1A2 inducer), phenobarbital (a CYP2B6 inducer), and rifampicin (a CYP3A4/5 inducer) served as positive controls. Data showed a strong correlation between the fold-increases in CYP activity, mRNA level, and protein level after incubation of the CYP isoforms with positive controls compared to the vehicle control. Ritonavir resulted in a decrease in CYP3A/5 activity, yet a concomitant increase in mRNA and protein levels of CYP3A4. Cytotoxicity was positive for staurosporine but negative for the other compounds. An ‘all-inclusive’ 96-well method for identifying potential drug–drug interactions in vitro was successfully developed and implemented. This is timely, as the recent FDA draft guidance on such studies now recommends using mRNA levels as an important endpoint." @default.
• W2051833837 created "2016-06-24" @default.
• W2051833837 creator A5014702263 @default.
• W2051833837 creator A5030865863 @default.
• W2051833837 creator A5033491672 @default.
• W2051833837 creator A5091508092 @default.
• W2051833837 date "2012-11-01" @default.
• W2051833837 modified "2023-10-12" @default.
• W2051833837 title "An ‘all-inclusive’ 96-well cytochrome P450 induction method: Measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes" @default.
• W2051833837 cites W1497221593 @default.
• W2051833837 cites W1967939624 @default.
• W2051833837 cites W1972097392 @default.
• W2051833837 cites W1992475241 @default.
• W2051833837 cites W1998622278 @default.
• W2051833837 cites W2014424798 @default.
• W2051833837 cites W2042763169 @default.
• W2051833837 cites W2054353003 @default.
• W2051833837 cites W2063539617 @default.
• W2051833837 cites W2089338956 @default.
• W2051833837 cites W2108859534 @default.
• W2051833837 cites W2119678057 @default.
• W2051833837 cites W2125021132 @default.
• W2051833837 cites W2126466225 @default.
• W2051833837 cites W2152964734 @default.
• W2051833837 cites W2154385453 @default.
• W2051833837 cites W3021092633 @default.
• W2051833837 doi "https://doi.org/10.1016/j.vascn.2012.07.004" @default.
• W2051833837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22809809" @default.
• W2051833837 hasPublicationYear "2012" @default.
• W2051833837 type Work @default.
• W2051833837 sameAs 2051833837 @default.
• W2051833837 citedByCount "29" @default.
• W2051833837 countsByYear W20518338372013 @default.
• W2051833837 countsByYear W20518338372014 @default.
• W2051833837 countsByYear W20518338372015 @default.
• W2051833837 countsByYear W20518338372016 @default.
• W2051833837 countsByYear W20518338372017 @default.
• W2051833837 countsByYear W20518338372018 @default.
• W2051833837 countsByYear W20518338372019 @default.
• W2051833837 countsByYear W20518338372020 @default.
• W2051833837 countsByYear W20518338372021 @default.
• W2051833837 countsByYear W20518338372022 @default.
• W2051833837 crossrefType "journal-article" @default.
• W2051833837 hasAuthorship W2051833837A5014702263 @default.
• W2051833837 hasAuthorship W2051833837A5030865863 @default.
• W2051833837 hasAuthorship W2051833837A5033491672 @default.
• W2051833837 hasAuthorship W2051833837A5091508092 @default.
• W2051833837 hasConcept C104317684 @default.
• W2051833837 hasConcept C109316439 @default.
• W2051833837 hasConcept C109650736 @default.
• W2051833837 hasConcept C132154277 @default.
• W2051833837 hasConcept C181199279 @default.
• W2051833837 hasConcept C185592680 @default.
• W2051833837 hasConcept C202751555 @default.
• W2051833837 hasConcept C2225953 @default.
• W2051833837 hasConcept C2778793413 @default.
• W2051833837 hasConcept C50605568 @default.
• W2051833837 hasConcept C526171541 @default.
• W2051833837 hasConcept C55493867 @default.
• W2051833837 hasConcept C86745063 @default.
• W2051833837 hasConcept C86803240 @default.
• W2051833837 hasConcept C98274493 @default.
• W2051833837 hasConceptScore W2051833837C104317684 @default.
• W2051833837 hasConceptScore W2051833837C109316439 @default.
• W2051833837 hasConceptScore W2051833837C109650736 @default.
• W2051833837 hasConceptScore W2051833837C132154277 @default.
• W2051833837 hasConceptScore W2051833837C181199279 @default.
• W2051833837 hasConceptScore W2051833837C185592680 @default.
• W2051833837 hasConceptScore W2051833837C202751555 @default.
• W2051833837 hasConceptScore W2051833837C2225953 @default.
• W2051833837 hasConceptScore W2051833837C2778793413 @default.
• W2051833837 hasConceptScore W2051833837C50605568 @default.
• W2051833837 hasConceptScore W2051833837C526171541 @default.
• W2051833837 hasConceptScore W2051833837C55493867 @default.
• W2051833837 hasConceptScore W2051833837C86745063 @default.
• W2051833837 hasConceptScore W2051833837C86803240 @default.
• W2051833837 hasConceptScore W2051833837C98274493 @default.
• W2051833837 hasIssue "3" @default.
• W2051833837 hasLocation W20518338371 @default.
• W2051833837 hasLocation W20518338372 @default.
• W2051833837 hasOpenAccess W2051833837 @default.
• W2051833837 hasPrimaryLocation W20518338371 @default.
• W2051833837 hasRelatedWork W1998541081 @default.
• W2051833837 hasRelatedWork W2028921444 @default.
• W2051833837 hasRelatedWork W2035465414 @default.
• W2051833837 hasRelatedWork W2078702135 @default.
• W2051833837 hasRelatedWork W2112546684 @default.
• W2051833837 hasRelatedWork W2145492382 @default.
• W2051833837 hasRelatedWork W2277368739 @default.
• W2051833837 hasRelatedWork W2510816179 @default.
• W2051833837 hasRelatedWork W2783899052 @default.
• W2051833837 hasRelatedWork W3016864177 @default.
• W2051833837 hasVolume "66" @default.
• W2051833837 isParatext "false" @default.
• W2051833837 isRetracted "false" @default.
• W2051833837 magId "2051833837" @default.
• W2051833837 workType "article" @default.